LRRK2 and Parkinson disease: It is worth noting that the treatment of PD is not limited to modulating the LRRK2 kinase activity, other physiological processes mediated by LRRK2 such as autophagy could also be potential therapeutic targets (Wojewska and Kortholt, 2021).